Table 2.
Factors | N (n progr.) | HR | Univariate |
Multivariate |
|||
---|---|---|---|---|---|---|---|
95% CI | p-Value | HR | 95% CI | p-Value | |||
Age | 29 | 0.98 | 0.94–1.03 | 0.600 | |||
Fuhrman tumor grade | |||||||
Grade 2 | 14 (7) | 1 | |||||
Grade >2 | 13 (4) | 0.39 | 0.11–1.41 | 0.393 | |||
Performance status | |||||||
0 | 18 (6) | 1 | |||||
1 | 13 (7) | 2.26 | 0. 75–6.77 | 0.146 | |||
Heng classification | |||||||
Good | 11 (6) | 1 | |||||
Intermediate | 14 (7) | 0.84 | 0.28–2.53 | 0.761 | |||
Neutrophyle-to-lymphocyte | |||||||
NLR <3 | 20 (10) | 1 | |||||
NLR ≥3 | 4 (3) | 2.49 | 0.68–9.20 | 0.169 | 6.92 | 1.09–44.03 | 0.040 |
Urine biomarker score | 29 | 4.62 | 1.66–12.83 | 0.003 | 5.38 | 1.65–17.57 | 0.005 |
Plasma biomarker score | 30 | 1.69 | 0.71–4.01 | 0.232 |